Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
Want to see LEGN full AI Analyst Report?
LEGN Analyst Ratings
Strong Buy
10 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LEGN Stock 12 Month Forecast
Average Price Target
$53.73
▲(153.80% Upside)
| Highest Price Target$80.00 | Average Price Target$53.73 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barclays
$80
Buy
277.89%
Upside
Assigned
04/20/26
H.C. Wainwright
$50
Buy
136.18%
Upside
Reiterated
04/20/26
Oppenheimer
$75
Buy
254.27%
Upside
Reiterated
04/20/26
Goldman Sachs
$44.47→$44.76
Buy
111.43%
Upside
Reiterated
04/14/26
RBC Capital
$62
Buy
192.87%
Upside
Reiterated
04/07/26
Truist Financial
$70
Buy
230.66%
Upside
Reiterated
03/13/26
Morgan Stanley
$50→$49
Buy
131.46%
Upside
Reiterated
03/11/26
Piper Sandler
$78
Buy
268.45%
Upside
Reiterated
03/11/26
TD Cowen
$21
Hold
-0.80%
Downside
Reiterated
03/10/26
Deutsche Bank
$60
Buy
183.42%
Upside
Reiterated
03/09/26
UBS
$31
Buy
46.43%
Upside
Reiterated
03/06/26
Rothschild & Co Redburn
$83→$24
Hold
13.37%
Upside
Downgraded
02/12/26
Cantor Fitzgerald
$75→$74
Buy
249.55%
Upside
Reiterated
12/17/25
William Blair
―
Hold
―
Reiterated
11/12/25
J.P. Morgan
$78→$76
Buy
259.00%
Upside
Reiterated
10/09/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
$80
Buy
277.89%
Upside
Assigned
04/20/26
H.C. Wainwright
$50
Buy
136.18%
Upside
Reiterated
04/20/26
Oppenheimer
$75
Buy
254.27%
Upside
Reiterated
04/20/26
Goldman Sachs
$44.47→$44.76
Buy
111.43%
Upside
Reiterated
04/14/26
RBC Capital
$62
Buy
192.87%
Upside
Reiterated
04/07/26
Truist Financial
$70
Buy
230.66%
Upside
Reiterated
03/13/26
Morgan Stanley
$50→$49
Buy
131.46%
Upside
Reiterated
03/11/26
Piper Sandler
$78
Buy
268.45%
Upside
Reiterated
03/11/26
TD Cowen
$21
Hold
-0.80%
Downside
Reiterated
03/10/26
Deutsche Bank
$60
Buy
183.42%
Upside
Reiterated
03/09/26
UBS
$31
Buy
46.43%
Upside
Reiterated
03/06/26
Rothschild & Co Redburn
$83→$24
Hold
13.37%
Upside
Downgraded
02/12/26
Cantor Fitzgerald
$75→$74
Buy
249.55%
Upside
Reiterated
12/17/25
William Blair
―
Hold
―
Reiterated
11/12/25
J.P. Morgan
$78→$76
Buy
259.00%
Upside
Reiterated
10/09/25
Best Analysts Covering Legend Biotech
3 Months
xxx
Success Rate
7/15 ratings generated profit
Average Return
+4.23%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +4.23% per trade.
1 Year
Success Rate
6/15 ratings generated profit
Average Return
-14.01%
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -14.01% per trade.
2 Years
xxx
Success Rate
12/32 ratings generated profit
Average Return
-11.33%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -11.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LEGN Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
20
22
16
19
20
Buy
1
0
0
0
0
Hold
1
2
2
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
24
18
22
22
Each month's total comprises the sum of three months' worth of ratings.
LEGN Financial Forecast
LEGN Stock Forecast FAQ
What is LEGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Legend Biotech Corporation’s 12-month average price target is 53.73.
What is LEGN’s upside potential, based on the analysts’ average price target?
Legend Biotech Corporation has 153.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LEGN a Buy, Sell or Hold?
Legend Biotech Corporation has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
What is Legend Biotech Corporation’s price target?
The average price target for Legend Biotech Corporation is 53.73. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $80.00 ,the lowest forecast is $21.00. The average price target represents 153.80% Increase from the current price of $21.17.
The highest analyst price target is $80.00 ,the lowest forecast is $21.00. The average price target represents 153.80% Increase from the current price of $21.17.
What do analysts say about Legend Biotech Corporation?
Legend Biotech Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of LEGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.